~ora-5139
What approaches does Ora use to drive trial acceleration and improved quality?
What services does Ora provide?
What is the Ora EyeCup™ technology powered by?
What is Sunya Andrews' role at Ora?
What are the potential risks of requiring difficult-to-assess inclusion criteria?
What is Paul Gomes' experience in clinical research?
What is Ora R&D creating in relation to the grading scale for LG in the conjunctiva?
How does Ora's approach maximize program efficiencies?
What is the contact number for Ora Headquarters?
What happens if a participant meets any of the exclusion criteria?
What are some examples of the medical devices Ora works with?
How long has the Ora Conjunctival Challenge Model (Ora-CAC) been used?
What are the benefits of using the Ora EyeCup™ in a clinical trial?
What are the areas of clinical expertise of the company?
What do drug and device programs require for patient targeting?
